Needs assessment and expected educational outcome 

To compare the pharmacodynamic profiles of the different lipid-lowering drugs to reach the treatment goal based on preexisting LDL-C levels during the index event, either by choosing the right dose or the right lipid-lowering drug combination as early as possible. The foregoing is the main focus of the webinar, together with a discussion of its impact on clinical outcome. Current guidelines do not support an early and strong reduction of LDL-C within a few days. A quick reduction of LDL-C to treatment goals or lower cannot be reached similarly by use of the different available lipid-lowering agents.

Learning objectives

After watching this webinar, participants will: 

• know the rationale of and biological mechanism associated with acute LDL-C reduction in ACS;

• know the pharmacodynamics profile of the different lipid-lowering drugs; and

• know the experience and clinical evidence of acute and strong LDL-C reduction in ACS. 

Main Topic

• Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care - Acute Coronary Syndromes - Prevention

Session information

This webinar is designed for general cardiologists, Acute Cardiac Syndrom filed of interest, ACVC Members but also cardiologists wishing to update their scientific knowledge on acute coronary syndrome topic.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).